Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?

Overview

Journal Antioxidants (Basel)

Date 2021 Nov 27

PMID 34829575

Citations 16

Authors

Lena Palaniyappan

Min Tae M Park

Peter Jeon

Roberto Limongi

Kun Yang

Akira Sawa

Jean Theberge

Affiliations

Soon will be listed here.

Abstract

Schizophrenia continues to be an illness with poor outcome. Most mechanistic changes occur many years before the first episode of schizophrenia; these are not reversible after the illness onset. A developmental mechanism that is still modifiable in adult life may center on intracortical glutathione (GSH). A large body of pre-clinical data has suggested the possibility of notable GSH-deficit in a subgroup of patients with schizophrenia. Nevertheless, studies of intracortical GSH are not conclusive in this regard. In this review, we highlight the recent ultra-high field magnetic resonance spectroscopic studies linking GSH to critical outcome measures across various stages of schizophrenia. We discuss the methodological steps required to conclusively establish or refute the persistence of subtype and clarify the role of the central antioxidant system in disrupting the brain structure and connectivity in the early stages of schizophrenia. We propose in-vivo GSH quantification for patient selection in forthcoming antioxidant trials in psychosis. This review offers directions for a promising non-dopaminergic early intervention approach in schizophrenia.

Citing Articles

Relevance of diet in schizophrenia: a review focusing on prenatal nutritional deficiency, obesity, oxidative stress and inflammation.

Rarinca V, Vasile A, Visternicu M, Burlui V, Halitchi G, Ciobica A Front Nutr. 2024; 11:1497569.

PMID: 39734678 PMC: 11673491. DOI: 10.3389/fnut.2024.1497569.

Schizophrenia and Glutathione: A Challenging Story.

Carletti B, Banaj N, Piras F, Bossu P J Pers Med. 2023; 13(11).

PMID: 38003841 PMC: 10672475. DOI: 10.3390/jpm13111526.

Glutathione Therapy in Diseases: Challenges and Potential Solutions for Therapeutic Advancement.

Dehkordi H, Ghasemi S Curr Mol Med. 2023; 24(10):1219-1230.

PMID: 37594114 DOI: 10.2174/1566524023666230818142831.

Critical Roles of the Cysteine-Glutathione Axis in the Production of γ-Glutamyl Peptides in the Nervous System.

Fujii J, Osaki T, Soma Y, Matsuda Y Int J Mol Sci. 2023; 24(9).

PMID: 37175751 PMC: 10179188. DOI: 10.3390/ijms24098044.

Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment.

De Simone G, Mazza B, Vellucci L, Barone A, Ciccarelli M, de Bartolomeis A Antioxidants (Basel). 2023; 12(4).

PMID: 37107350 PMC: 10135787. DOI: 10.3390/antiox12040975.

References

Solberg D, Refsum H, Andreassen O, Bentsen H . A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia. Acta Neuropsychiatr. 2019; 31(4):202-212. DOI: 10.1017/neu.2019.14. View

Cardis R, Cabungcal J, Dwir D, Do K, Steullet P . A lack of GluN2A-containing NMDA receptors confers a vulnerability to redox dysregulation: Consequences on parvalbumin interneurons, and their perineuronal nets. Neurobiol Dis. 2017; 109(Pt A):64-75. DOI: 10.1016/j.nbd.2017.10.006. View

Cunha Xavier Pinto M, Mourao F, Binda N, Leite H, Gomez M, Massensini A . Pharmacological induction of ischemic tolerance in hippocampal slices by sarcosine preconditioning. Neurochem Int. 2012; 61(5):713-20. DOI: 10.1016/j.neuint.2012.06.018. View

Sinha R, Sinha I, Calcagnotto A, Trushin N, Haley J, Schell T . Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr. 2017; 72(1):105-111. PMC: 6389332. DOI: 10.1038/ejcn.2017.132. View

Nazeri A, Mulsant B, Rajji T, Levesque M, Pipitone J, Stefanik L . Gray Matter Neuritic Microstructure Deficits in Schizophrenia and Bipolar Disorder. Biol Psychiatry. 2017; 82(10):726-736. DOI: 10.1016/j.biopsych.2016.12.005. View

Do K, Trabesinger A, Lauer C, Dydak U, Hell D, Holsboer F . Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci. 2000; 12(10):3721-8. DOI: 10.1046/j.1460-9568.2000.00229.x. View

Chen J, Yadav N, Stait-Gardner T, Gupta A, Price W, Zheng G . Thiol-water proton exchange of glutathione, cysteine, and N-acetylcysteine: Implications for CEST MRI. NMR Biomed. 2019; 33(1):e4188. DOI: 10.1002/nbm.4188. View

Monte A, Mello B, Borella V, Araujo T, da Silva F, de Sousa F . Two-hit model of schizophrenia induced by neonatal immune activation and peripubertal stress in rats: Study of sex differences and brain oxidative alterations. Behav Brain Res. 2017; 331:30-37. DOI: 10.1016/j.bbr.2017.04.057. View

Limongi R, Jeon P, Theberge J, Palaniyappan L . Counteracting Effects of Glutathione on the Glutamate-Driven Excitation/Inhibition Imbalance in First-Episode Schizophrenia: A 7T MRS and Dynamic Causal Modeling Study. Antioxidants (Basel). 2021; 10(1). PMC: 7828075. DOI: 10.3390/antiox10010075. View

10.

Bottino F, Lucignani M, Napolitano A, Dellepiane F, Visconti E, Rossi Espagnet M . In Vivo Brain GSH: MRS Methods and Clinical Applications. Antioxidants (Basel). 2021; 10(9). PMC: 8468877. DOI: 10.3390/antiox10091407. View

11.

Fisher E, Gillam J, Upthegrove R, Aldred S, Wood S . Role of magnetic resonance spectroscopy in cerebral glutathione quantification for youth mental health: A systematic review. Early Interv Psychiatry. 2019; 14(2):147-162. PMC: 7065077. DOI: 10.1111/eip.12833. View

12.

Justin A, Sathishkumar M, Sudheer A, Shanthakumari S, Ramanathan M . Non-hypotensive dose of telmisartan and nimodipine produced synergistic neuroprotective effect in cerebral ischemic model by attenuating brain cytokine levels. Pharmacol Biochem Behav. 2014; 122:61-73. DOI: 10.1016/j.pbb.2014.03.009. View

13.

Sharma A, Gerbarg P, Bottiglieri T, Massoumi L, Carpenter L, Lavretsky H . S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research. J Clin Psychiatry. 2017; 78(6):e656-e667. PMC: 5501081. DOI: 10.4088/JCP.16r11113. View

14.

Liang M, Wang Z, Li H, Cai L, Pan J, He H . l-Arginine induces antioxidant response to prevent oxidative stress via stimulation of glutathione synthesis and activation of Nrf2 pathway. Food Chem Toxicol. 2018; 115:315-328. DOI: 10.1016/j.fct.2018.03.029. View

15.

Maas D, Valles A, Martens G . Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia. Transl Psychiatry. 2017; 7(7):e1171. PMC: 5538118. DOI: 10.1038/tp.2017.138. View

16.

Dempster K, Jeon P, Mackinley M, Williamson P, Theberge J, Palaniyappan L . Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate. Mol Psychiatry. 2020; 25(8):1640-1650. PMC: 7387300. DOI: 10.1038/s41380-020-0704-x. View

17.

Berk M, Malhi G, Gray L, Dean O . The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci. 2013; 34(3):167-77. DOI: 10.1016/j.tips.2013.01.001. View

18.

Croteau-Chonka E, Dean 3rd D, Remer J, Dirks H, OMuircheartaigh J, Deoni S . Examining the relationships between cortical maturation and white matter myelination throughout early childhood. Neuroimage. 2015; 125:413-421. PMC: 4691410. DOI: 10.1016/j.neuroimage.2015.10.038. View

19.

Fernandez-Fernandez S, Bobo-Jimenez V, Requejo-Aguilar R, Gonzalez-Fernandez S, Resch M, Carabias-Carrasco M . Hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function. Redox Biol. 2018; 19:52-61. PMC: 6092450. DOI: 10.1016/j.redox.2018.08.003. View

20.

Godlewska B, Minichino A, Emir U, Angelescu I, Lennox B, Micunovic M . Brain glutamate concentration in men with early psychosis: a magnetic resonance spectroscopy case-control study at 7 T. Transl Psychiatry. 2021; 11(1):367. PMC: 8257573. DOI: 10.1038/s41398-021-01477-6. View